$1.2 Billion is the total value of BRIDGER MANAGEMENT, LLC's 34 reported holdings in Q4 2018. The portfolio turnover from Q3 2018 to Q4 2018 was 35.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ATRA | Sell | ATARA BIOTHERAPEUTICS INC | $76,668,000 | -24.6% | 2,206,917 | -10.3% | 6.39% | +8.6% |
| GDDY | GODADDY INCcl a | $72,635,000 | -21.3% | 1,106,900 | 0.0% | 6.06% | +13.4% | |
| HRTX | Buy | HERON THERAPEUTICS INC | $64,391,000 | -11.2% | 2,482,309 | +8.4% | 5.37% | +28.0% |
| POST | Sell | POST HLDGS INC | $63,264,000 | -30.3% | 709,796 | -23.3% | 5.27% | +0.4% |
| MDCO | Buy | MEDICINES CO | $58,581,000 | -16.3% | 3,060,671 | +30.8% | 4.88% | +20.6% |
| MS | Buy | MORGAN STANLEY | $54,055,000 | +1.5% | 1,363,307 | +19.3% | 4.51% | +46.3% |
| DRNA | Sell | DICERNA PHARMACEUTICALS INC | $51,031,000 | -39.5% | 4,773,718 | -13.7% | 4.25% | -12.9% |
| CHTR | Sell | CHARTER COMMUNICATIONS INC Ncl a | $48,858,000 | -20.3% | 171,451 | -8.9% | 4.07% | +14.8% |
| MGM | Buy | MGM RESORTS INTERNATIONAL | $48,197,000 | -11.6% | 1,986,689 | +1.7% | 4.02% | +27.4% |
| ALNY | Sell | ALNYLAM PHARMACEUTICALS INC | $48,032,000 | -24.1% | 658,785 | -8.9% | 4.00% | +9.4% |
| FDC | FIRST DATA CORP NEW | $44,964,000 | -30.9% | 2,658,994 | 0.0% | 3.75% | -0.4% | |
| IRWD | Buy | IRONWOOD PHARMACEUTICALS INC | $43,324,000 | +277.4% | 4,181,892 | +572.4% | 3.61% | +444.0% |
| VRSN | Buy | VERISIGN INC | $43,129,000 | +101.8% | 290,843 | +117.9% | 3.60% | +190.9% |
| ERI | ELDORADO RESORTS INC | $40,296,000 | -25.5% | 1,112,836 | 0.0% | 3.36% | +7.4% | |
| WMGI | Sell | WRIGHT MED GROUP N V | $38,768,000 | -39.9% | 1,424,239 | -35.9% | 3.23% | -13.4% |
| NKTR | NEKTAR THERAPEUTICS | $37,288,000 | -46.1% | 1,134,414 | 0.0% | 3.11% | -22.3% | |
| VSAT | VIASAT INC | $33,659,000 | -7.8% | 570,979 | 0.0% | 2.81% | +32.9% | |
| GDS | New | GDS HLDGS LTDsponsored adr | $32,084,000 | – | 1,389,514 | +100.0% | 2.68% | – |
| CZR | Buy | CAESARS ENTMT CORP | $30,235,000 | +0.7% | 4,452,889 | +51.9% | 2.52% | +45.0% |
| LBRDA | LIBERTY BROADBAND CORP | $28,027,000 | -14.8% | 390,292 | 0.0% | 2.34% | +22.7% | |
| RCKT | ROCKET PHARMACEUTICALS INC | $25,978,000 | -39.8% | 1,752,902 | 0.0% | 2.17% | -13.3% | |
| TEVA | TEVA PHARMACEUTICAL INDS LTDsponsored adr | $23,130,000 | -28.4% | 1,500,000 | 0.0% | 1.93% | +3.2% | |
| SHAK | New | SHAKE SHACK INCcl a | $20,753,000 | – | 456,923 | +100.0% | 1.73% | – |
| GDEN | Buy | GOLDEN ENTMT INC | $20,550,000 | -5.1% | 1,282,755 | +42.3% | 1.71% | +36.8% |
| ALXN | New | ALEXION PHARMACEUTICALS INC | $19,477,000 | – | 200,049 | +100.0% | 1.62% | – |
| WCG | New | WELLCARE HEALTH PLANS INC | $18,844,000 | – | 79,816 | +100.0% | 1.57% | – |
| CNC | New | CENTENE CORP DEL | $18,518,000 | – | 160,609 | +100.0% | 1.54% | – |
| STAA | New | STAAR SURGICAL CO | $16,405,000 | – | 514,105 | +100.0% | 1.37% | – |
| TGTX | Buy | TG THERAPEUTICS INC | $15,545,000 | +26.8% | 3,791,531 | +73.1% | 1.30% | +82.8% |
| CSII | Buy | CARDIOVASCULAR SYS INC DEL | $15,274,000 | -16.6% | 536,128 | +14.6% | 1.27% | +20.2% |
| PVG | PRETIUM RES INC | $13,954,000 | +11.0% | 1,651,328 | 0.0% | 1.16% | +60.0% | |
| AMRX | Sell | AMNEAL PHARMACEUTICALS INC | $13,820,000 | -76.4% | 1,021,420 | -61.3% | 1.15% | -66.0% |
| WVE | Sell | WAVE LIFE SCIENCES LTD | $13,091,000 | -37.1% | 311,393 | -25.1% | 1.09% | -9.3% |
| DXCM | Sell | DEXCOM INC | $6,764,000 | -88.2% | 56,457 | -85.9% | 0.56% | -82.9% |
| TSLA | Exit | TESLA INCput | $0 | – | -100,000 | -100.0% | -1.53% | – |
| SMG | Exit | SCOTTS MIRACLE GRO COcl a | $0 | – | -369,057 | -100.0% | -1.68% | – |
| ATVI | Exit | ACTIVISION BLIZZARD INC | $0 | – | -360,000 | -100.0% | -1.73% | – |
| MSGN | Exit | MSG NETWORK INCcl a | $0 | – | -1,346,056 | -100.0% | -2.01% | – |
| ZBH | Exit | ZIMMER BIOMET HLDGS INC | $0 | – | -705,143 | -100.0% | -5.36% | – |
| HCA | Exit | HCA HEALTHCARE INC | $0 | – | -789,399 | -100.0% | -6.35% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-02-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VERISIGN INC | 40 | Q1 2023 | 5.2% |
| TEVA PHARMACEUTICAL INDS LTD | 40 | Q3 2023 | 7.3% |
| MORGAN STANLEY | 35 | Q3 2023 | 11.8% |
| ALNYLAM PHARMACEUTICALS INC | 34 | Q3 2021 | 4.9% |
| POST HLDGS INC | 33 | Q4 2022 | 6.1% |
| TG THERAPEUTICS INC | 33 | Q3 2021 | 3.8% |
| CHARTER COMMUNICATIONS INC N | 30 | Q3 2023 | 7.2% |
| ATARA BIOTHERAPEUTICS INC | 29 | Q4 2021 | 6.4% |
| GODADDY INC | 28 | Q3 2023 | 8.9% |
| CENTENE CORP DEL | 28 | Q3 2022 | 6.2% |
View BRIDGER MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Surrozen, Inc./DESold out | February 14, 2022 | 0 | 0.0% |
| Atara Biotherapeutics, Inc. | February 16, 2021 | 1,524,760 | 1.8% |
| Dicerna Pharmaceuticals Inc | February 14, 2020 | 1,981,633 | 2.9% |
| TG THERAPEUTICS, INC. | February 14, 2020 | 1,907,492 | 1.9% |
| CHIMERIX INCSold out | February 14, 2017 | 0 | 0.0% |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC.Sold out | February 14, 2017 | 0 | 0.0% |
| SeaSpine Holdings CorpSold out | February 14, 2017 | 0 | 0.0% |
| Trovagene, Inc.Sold out | February 14, 2017 | 0 | 0.0% |
| ARROWHEAD RESEARCH CORPSold out | February 16, 2016 | 0 | 0.0% |
| PENNYMAC FINANCIAL SERVICES, INC.Sold out | February 16, 2016 | 0 | 0.0% |
View BRIDGER MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
View BRIDGER MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.